Protagenic Therapeutics Overview
Latest P/E ratio for Protagenic Therapeutics: 0.3 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.30
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, PTIX shows a P/E ratio of 0.3. That is below the Industrials sector average of 29.15. Scroll down for historical charts and peer comparison views.
The Industrials sector average P/E ratio is about 29.15. Protagenic Therapeutics is at 0.3, which is lower that average. That is roughly 99.0% below the sector mean. Use the comparison chart on this page to see how PTIX stacks up against individual peers as well.
Investors watch PTIX's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Protagenic Therapeutics's latest reading is 0.3. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Protagenic Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 0.3) with ownership activity and broader fundamentals.
The Industrials average P/E ratio is about 29.15, while PTIX is at 0.3. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
